However, S100A4 knockdown did not exhibit higher cytotoxicity in DLD-1-HMGA2 cells as niclosamide did (Figure 8E), confirming that S100A4 downregulation was not sufficient to selectively kill HMGA2-overexpressing colorectal cancer cells. The gene discussed is S100A4; the disease is colorectal cancer.